A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption

ConclusionsOral 25(OH)D3 may be a good choice for managing vitamin D deficiency in malabsorption and obesity. This trial was registered atclinicaltrials.gov as (NCT03401541.
Source: American Journal of Clinical Nutrition - Category: Nutrition Source Type: research